subperiosteal implants
Biocompatibility of Subperiosteal Dental Implants: Influence of Different Titanium Surface Treatments on Extracellular Matrix Gene Expression in Gingival Fibroblasts
- 20 January 2023
- Posted by: anjaform
- Category: Biomaterials
Marco Roy, Alessandro Corti, Silvia Dominici, Alfonso Pompella, Mauro Cerea, Elisa Chelucci, Barbara Dorocka-Bobkowska, Simona Daniele.
Full text link: https://pubmed.ncbi.nlm.nih.gov/36826858/
Biocompatibility of Subperiosteal Dental Implants: Influence of Different Titanium Surface Treatments on Extracellular Matrix Gene Expression in Gingival Fibroblasts
1. Scientific Reference
- Study Title: Biocompatibility of Subperiosteal Dental Implants: Effects of Differently Treated Titanium Surfaces on the Expression of ECM-Related Genes in Gingival Fibroblasts
- Authors: Marco Roy, Alessandro Corti, Silvia Dominici, Alfonso Pompella, Mauro Cerea, Elisa Chelucci, Barbara Dorocka-Bobkowska, Simona Daniele.
- Journal: Journal of Functional Biomaterials
- Publication Year: 2023.
- DOI: 10.3390/jfb14020059.
2. Scientific Background
Advances in digital dentistry and additive manufacturing have renewed interest in subperiosteal dental implants as an alternative treatment for patients with severe maxillary bone resorption. These custom-made titanium frameworks are increasingly produced through selective laser melting (SLM), enabling highly individualized implant designs that would be difficult to manufacture using conventional subtractive techniques.
Unlike conventional endosseous implants, subperiosteal implants establish extensive contact with both bone and peri-implant soft tissues. Consequently, their long-term biological performance depends not only on osseointegration but also on the quality of soft tissue healing and connective tissue attachment. Gingival fibroblasts play a central role in these processes by contributing to extracellular matrix organization, wound healing, and peri-implant tissue stability. Although numerous titanium surface modifications have been developed to enhance implant biocompatibility, comparatively little information is available regarding their specific effects on fibroblast behavior in the context of subperiosteal implantology. This study addresses that knowledge gap by comparing several clinically relevant titanium surface treatments under standardized laboratory conditions.
3. Study Objective
The primary objective of this investigation was to determine whether different titanium surface treatments used for subperiosteal dental implants influence the biological response of human gingival fibroblasts. The authors evaluated cell viability, proliferation, migration, inflammatory response, and the expression of extracellular matrix-related genes associated with cellular adhesion and differentiation in order to identify surface characteristics that may better support soft tissue integration.
4. Methodology
This research was designed as an in vitro experimental study using an immortalized human gingival fibroblast cell line (CRL-4061). Five commercially pure titanium surface conditions were investigated: raw machined (Ti-1), electropolished (Ti-2), sand-blasted and acid-etched (Ti-3), the proprietary AlTiColor™ surface (Ti-4), and anodized titanium (Ti-5).
Multiple biological endpoints were assessed throughout the experiment. Cell viability and proliferation were measured using resazurin assays, while immunofluorescence microscopy was employed to evaluate cell morphology. Gene expression analysis focused on extracellular matrix and adhesion-related markers, including vinculin, fibronectin, collagen type I alpha-1, and integrin β1. Protein expression was further investigated using ELISA assays, and fibroblast migration was quantified through scratch wound experiments. Endothelin-1 release was also measured as an indicator of inflammatory activation. Each experimental condition was reproduced in independent experiments to improve data reliability.
5. Key Findings
The experimental results demonstrated that none of the five titanium surface treatments produced measurable cytotoxic effects on human gingival fibroblasts. Cell viability and proliferation remained comparable to control cultures throughout the observation period, indicating that all tested surfaces provided a biologically compatible environment for fibroblast survival. Likewise, endothelin-1 secretion, which was assessed as an indicator of inflammatory activation, showed no statistically significant differences among the different surface treatments, suggesting that none of the evaluated titanium finishes elicited a detectable pro-inflammatory response under the experimental conditions.
More substantial differences emerged when cellular functions related to extracellular matrix organization and soft tissue integration were examined. All titanium surfaces enhanced, to varying degrees, the expression of genes involved in fibroblast adhesion and differentiation, including vinculin (VCL), fibronectin (FN), collagen type I alpha-1 (Col1A1), and integrin β1 (ITGB1). Protein analyses further supported these findings by demonstrating changes in adhesion-related markers such as focal adhesion kinase (FAK) and N-cadherin, although the magnitude of these responses varied according to surface treatment.
Scratch wound assays revealed that fibroblasts were capable of proliferating and migrating across all titanium surfaces, confirming the ability of each material to support cellular repopulation. However, migration efficiency differed among the tested surfaces. According to the authors, biological performance ranked as follows:
- Ti-3 (sand-blasted and acid-etched)
- Ti-4 (AlTiColor™)
- Ti-5 (anodized)
- Ti-2 (electropolished)
- Ti-1 (raw machined)
Based on these observations, the investigators identified the sand-blasted and acid-etched surface as the most favorable treatment for promoting fibroblast functions associated with early soft tissue integration around subperiosteal dental implants. This conclusion, however, remains limited to the in vitro model investigated in this study.
6. Clinical Analysis
This study expands current knowledge by focusing on an aspect of implant biology that has received comparatively less attention than osseointegration: the interaction between implant surfaces and peri-implant soft tissues. For subperiosteal implants, which are designed to rest directly beneath the periosteum and remain in close contact with gingival connective tissue, successful healing depends not only on bone compatibility but also on the biological response of gingival fibroblasts. These cells are fundamental for extracellular matrix synthesis, connective tissue attachment, and the establishment of a stable peri-implant soft tissue seal.
One of the most relevant findings is that all evaluated titanium surfaces demonstrated excellent biocompatibility, with no evidence of cytotoxicity or increased inflammatory signaling. This confirms that the tested manufacturing and finishing procedures are compatible with fibroblast survival under laboratory conditions. More importantly, the study suggests that surface microtopography may influence cellular behavior beyond simple viability, particularly with respect to adhesion, differentiation, and migration, which represent critical early events during soft tissue healing following implant placement.
From a clinical perspective, the superior biological performance observed with the sand-blasted and acid-etched surface may be relevant for manufacturers seeking to optimize subperiosteal implant design. Nevertheless, these findings should not be interpreted as direct evidence of improved clinical outcomes. The investigation did not evaluate implant survival, peri-implant tissue stability, complication rates, or patient-reported outcomes. Consequently, it cannot establish whether enhanced fibroblast activity translates into superior long-term clinical performance.
Instead, the study should be viewed as an important piece of preclinical evidence supporting further translational research. Future animal studies and well-designed clinical investigations will be necessary to determine whether these cellular responses ultimately improve wound healing, soft tissue integration, and the long-term success of digitally manufactured subperiosteal implant rehabilitations.
7. Clinical Applications
The findings of this study are primarily applicable to the design and optimization of digitally manufactured subperiosteal dental implants intended for patients with advanced maxillary bone atrophy. In these complex rehabilitation scenarios, titanium surface characteristics may represent an additional factor influencing the biological interaction between the implant framework and surrounding soft tissues.
The study is particularly relevant for implant systems produced through selective laser melting (SLM) and integrated into fully digital CAD/CAM workflows. Within this context, selecting an appropriate surface treatment could contribute to creating a biological environment that favors fibroblast attachment and early connective tissue healing following implant placement.
Although the sand-blasted and acid-etched titanium surface demonstrated the most favorable cellular response among the treatments investigated, the present data should not be interpreted as evidence supporting a specific surgical protocol or a clinically superior implant system. The study exclusively evaluates cellular responses under controlled laboratory conditions and does not provide clinical outcome data such as implant survival, peri-implant tissue stability, prosthetic success, or complication rates.
8. Level of Evidence, Limitations, and Transparency
This publication represents an in vitro experimental study, corresponding to preclinical evidence. Its principal contribution lies in improving the understanding of how different titanium surface treatments influence the biological behavior of gingival fibroblasts, rather than evaluating the clinical performance of subperiosteal implants in patients.
Several limitations should be considered when interpreting the findings. The experiments were performed using an immortalized human gingival fibroblast cell line under controlled laboratory conditions. Consequently, the model cannot fully reproduce the biological complexity of the oral environment, including vascularization, immune responses, bacterial biofilm formation, functional loading, and patient-related variability. Furthermore, the study does not include animal experiments, clinical follow-up, or long-term outcome assessments. Therefore, no conclusions can be drawn regarding implant longevity or clinical success.
Regarding transparency, the titanium specimens were supplied by NewAncorvis Srl., while the different surface treatments were performed by Al Ti Color Srl. according to their respective manufacturing procedures. Within the information available in the article, no explicit declaration of conflicts of interest related to these companies is reported.
9. Key Study Highlights
- Study design: In vitro experimental investigation.
- Level of evidence: Preclinical laboratory study.
- Study population: Immortalized human gingival fibroblasts (CRL-4061 cell line).
- Number of patients: Not applicable.
- Number of implants: Not applicable.
- Follow-up period: Biological evaluations performed up to 72 hours of cell culture.
- Primary outcome: Assessment of five titanium surface treatments on fibroblast viability, proliferation, migration, inflammatory response, and extracellular matrix-related gene expression.
- Main finding: All tested titanium surfaces exhibited good biocompatibility, while the sand-blasted and acid-etched surface generated the most favorable cellular responses associated with soft tissue integration.
- Scientific conclusion: Among the evaluated surface treatments, sand-blasting followed by acid etching appears to provide the most favorable biological environment for gingival fibroblast attachment and migration within the limitations of an in vitro model.
- Main limitations: In vitro design, absence of clinical validation, and lack of long-term biological or prosthetic outcome data.
10. Scientific Impact
This study contributes valuable preclinical evidence to an emerging area of implant dentistry by investigating how titanium surface engineering may influence soft tissue integration around subperiosteal dental implants. While implant research has traditionally focused on osseointegration, this work emphasizes the biological importance of peri-implant connective tissues and the role of gingival fibroblasts in establishing a stable soft tissue interface.
A notable strength of the investigation is the standardized comparison of five clinically relevant titanium surface treatments under identical experimental conditions. Rather than demonstrating differences in overall biocompatibility, the study identifies variations in cellular functions that may influence early wound healing and extracellular matrix organization. These findings provide mechanistic insights into how surface microtopography can modulate fibroblast behavior without inducing cytotoxicity or inflammatory activation.
From a broader scientific perspective, this work establishes a foundation for future translational research. The observed cellular responses justify further investigation through animal models and prospective clinical studies designed to determine whether improved fibroblast adhesion and migration ultimately translate into enhanced peri-implant soft tissue stability, improved wound healing, and better long-term outcomes for patients undergoing complex implant rehabilitation with custom-made subperiosteal implants.
11. Editorial Conclusion
This preclinical investigation provides meaningful evidence that titanium surface modification can influence key biological processes involved in peri-implant soft tissue healing without compromising overall biocompatibility. Among the evaluated treatments, the sand-blasted and acid-etched surface demonstrated the most favorable effects on fibroblast behavior associated with extracellular matrix formation and cellular migration. Although these findings cannot be directly extrapolated to clinical practice, they offer valuable insight into the biological optimization of digitally manufactured subperiosteal implants and support the need for well-designed clinical studies to validate their long-term therapeutic relevance.
